[1] 中华医学会呼吸病学分会睡眠呼吸疾病学组.  阻塞性睡眠呼吸暂停低通气综合征诊治指南(草案)[J]. 中华内科杂志, 2003, 42(8): 594-597.   doi: 10.3760/j.issn:0578-1426.2003.08.033
[2] 何权瀛.  我国阻塞性睡眠呼吸暂停低通气综合征的诊断和治疗中的几个问题[J]. 临床内科杂志, 2004, 21(1): 34-35.   doi: 10.3969/j.issn.1001-9057.2004.01.014
[3] 徐济民.  缺血性心脏病诊断的命名及标准—国际心脏病学会和协会/世界卫生组织临床命名标准化专题组的联合报告[J]. 国外心血管病分册, 1979, 6: 365-366.
[4] Gozal D, Kheirandish-Gozal L.  Cardiovascular morbidity in obstructive sleep apnea oxidative stress, inflammation, and much more[J]. Am J Respir Crit Care Med, 2008, 177(4): 369-375.   doi: 10.1164/rccm.200608-1190PP
[5] Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al.  Elevated Creactive protein in patients with obstructive sleep apnea[J]. Circulation, 2002, 105(21): 2462-2464.   doi: 10.1161/01.CIR.0000018948.95175.03
[6] Dai J, Li W, Chang L, et al.  Role of redox factor-1 in hyperhocysteinemia-accelerated atherosclerosis[J]. Free Radic Biol Med, 2006, 41(10): 1566-1577.   doi: 10.1016/j.freeradbiomed.2006.08.020
[7] Hatipoglu U, Rubinstein I.  Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis[J]. Respiration, 2003, 70(6): 665-671.   doi: 10.1159/000075218